The Promising Evolution of Targeted Therapeutic Strategies in Cancer

Solange Peters1, Tony Mok2, Antonio Passaro3

  • 1Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. solange.peters@chuv.ch.

Cancer Discovery
|April 3, 2021
PubMed

Insights

Precision medicine in cancer care is advancing beyond genetic mutations. Future strategies will integrate analyses of the tumor microenvironment for improved early and metastatic disease treatments.

Area of Science:

  • Oncology
  • Genomics
  • Immunology

Background:

  • Precision medicine has historically focused on translating specific genetic findings into cancer treatments.
  • The current paradigm is shifting towards a more comprehensive understanding of the tumor ecosystem.

Purpose of the Study:

  • To outline the future direction of precision medicine in oncology.
  • To emphasize the integration of genomic and immune analyses of the tumor microenvironment.

Main Methods:

  • Qualitative analyses of the tumor microenvironment.
  • Integration of genomic and immune data.
  • Application to both early and metastatic cancer stages.

Main Results:

  • Anticipated shift from genetic-specific to microenvironment-integrated treatment strategies.
  • Development of comprehensive treatment approaches for diverse cancer stages.

Conclusions:

  • The next decade of cancer precision medicine will leverage integrated analyses of the tumor microenvironment.
  • This approach aims to enhance treatment strategies for both early-stage and metastatic cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K